These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10513855)

  • 61. Paroxetine: a review.
    Bourin M; Chue P; Guillon Y
    CNS Drug Rev; 2001; 7(1):25-47. PubMed ID: 11420571
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Depressing misrepresentation?
    Newton J; Langlands A
    Lancet; 2004 May; 363(9422):1732. PubMed ID: 15158640
    [No Abstract]   [Full Text] [Related]  

  • 63. Executive functioning, illness course, and relapse/recurrence in continuation and maintenance treatment of late-life depression: is there a relationship?
    Butters MA; Bhalla RK; Mulsant BH; Mazumdar S; Houck PR; Begley AE; Dew MA; Pollock BG; Nebes RD; Becker JT; Reynolds CF
    Am J Geriatr Psychiatry; 2004; 12(4):387-94. PubMed ID: 15249276
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.
    Mazeh D; Shahal B; Aviv A; Zemishlani H; Barak Y
    Int Clin Psychopharmacol; 2007 Nov; 22(6):371-5. PubMed ID: 17917556
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization.
    Sheffield RE; Lo Sasso AT; Young CH; Way K
    Adm Policy Ment Health; 2002 Nov; 30(2):121-39. PubMed ID: 12680617
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A review of the psychomotor effects of paroxetine.
    Hindmarch I
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():65-7. PubMed ID: 1431014
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Paroxetine (paxil): use in clinical practice].
    Litvintsev SV; Reznik AM; Arbuzov AL; Mironychev GN
    Voen Med Zh; 2002 Jan; 323(1):35-9. PubMed ID: 11881199
    [No Abstract]   [Full Text] [Related]  

  • 68. Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients.
    Mamo DC; Sweet RA; Mulsant BH; Pollock BG; Miller MD; Stack JA; Begley AE; Reynolds CF
    Am J Geriatr Psychiatry; 2000; 8(3):226-31. PubMed ID: 10910421
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
    Gunasekara NS; Noble S; Benfield P
    Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
    [TBL] [Abstract][Full Text] [Related]  

  • 70. FDA questions antidepressant safety for children.
    Oransky I
    Lancet; 2003 Nov; 362(9395):1558. PubMed ID: 14627000
    [No Abstract]   [Full Text] [Related]  

  • 71. Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression: a randomized, placebo-controlled study.
    Smith GS; Reynolds CF; Houck PR; Dew MA; Ginsberg J; Ma Y; Mulsant BH; Pollock BG
    Psychiatry Res; 2009 Jan; 171(1):1-9. PubMed ID: 19087899
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery.
    Herrera-Guzmán I; Gudayol-Ferré E; Herrera-Abarca JE; Herrera-Guzmán D; Montelongo-Pedraza P; Padrós Blázquez F; Peró-Cebollero M; Guàrdia-Olmos J
    J Affect Disord; 2010 Jun; 123(1-3):341-50. PubMed ID: 19896719
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Changes in cognitive functioning following treatment of late-life depression.
    Butters MA; Becker JT; Nebes RD; Zmuda MD; Mulsant BH; Pollock BG; Reynolds CF
    Am J Psychiatry; 2000 Dec; 157(12):1949-54. PubMed ID: 11097959
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Depression: making the diagnosis and using SSRIs in the older patient.
    Reynolds CF
    Geriatrics; 1996 Oct; 51(10):28-34. PubMed ID: 8863755
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A comparison of paroxetine and placebo in depressed outpatients.
    Dunbar GC; Claghorn JL; Kiev A; Rickels K; Smith WT
    Acta Psychiatr Scand; 1993 May; 87(5):302-5. PubMed ID: 8517168
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Urticarial vasculitis secondary to paroxetine.
    Welsh JP; Cusack CA; Ko C
    J Drugs Dermatol; 2006; 5(10):1012-4. PubMed ID: 17373154
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dose-dependent pharmacokinetic interaction of clozapine and paroxetine in an extensive metabolizer.
    Joos AA; König F; Frank UG; Kaschka WP; Mörike KE; Ewald R
    Pharmacopsychiatry; 1997 Nov; 30(6):266-70. PubMed ID: 9442550
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Delirium associated with paroxetine in an elderly depressive patient: a case report.
    Wakeno M; Okugawa G; Takekita Y; Kato M; Fukuda T; Yamashita M; Hosoi Y; Azuma J; Kinoshita T
    Pharmacopsychiatry; 2007 Sep; 40(5):199-200. PubMed ID: 17874351
    [No Abstract]   [Full Text] [Related]  

  • 80. Sexual function during bupropion or paroxetine treatment of major depressive disorder.
    Kennedy SH; Fulton KA; Bagby RM; Greene AL; Cohen NL; Rafi-Tari S
    Can J Psychiatry; 2006 Mar; 51(4):234-42. PubMed ID: 16629348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.